Search
Searching with a thematic focus on HIV and AIDS in Ethiopia
Showing 41-45 of 45 results
Pages
- Document
FHI/UNAIDS best practices in HIV/AIDS prevention collection
Family Health International, 2001This collection of work is centred on HIV/AIDS prevention in the non-industrialised world and is based on studies performed by FHI's international and local partners in an international HIV prevention, the AIDS Control and Prevention (AIDSCAP) Project.The book offers case studies, models and lessons learnt to assist individuals, communities, municipalities, non-governmental organisations, businDocumentStatus and impacts of HIV/AIDS in agricultural universities and colleges in Africa
Noragric, Department of International Environment and Development Studies, Norwegian University of Life Sciences, 2002The report looks into the status, impact and preventive actions taken by some of the partner universities and colleges in Africa of Agricultural University of Norway (NLH) against the spread of HIV/AIDS.DocumentAIDS in Ethiopia: fourth edition
Policy Project, Futures Group, Washington, 2002This update on HIV/AIDS in Ethiopia is based on double the amount of data previously used to estimate prevalence in the country.DocumentUnderstanding HIV-related stigma and resulting discrimination in Sub-Saharan Africa: emerging themes from early data collection in Ethiopia, Tanzania and Zambia
International Center for Research on Women, USA, 2002Describes research that is underway in three African countries and Vietnam to investigate the causes, manifestations, and consequences of HIV/AIDS-related stigma and subsequent discriminatory acts. The basis for analysis is the community and its institutions (health facilities, the workplace, schools, and religious group)s.DocumentPatent protection and access to HIV/AIDS pharmaceuticals in Sub-Saharan Africa
World Intellectual Property Organization, 2000This paper reviews the TRIPS patent and, in particular, those provisions relevant to the issue of pharmaceuticals and the patent situation in sub-Saharan Africa with regard to the protection of anti-retroviral HIV/AIDS drugs. Patent offices and pharmaceutical companies were surveyed to discover the extent to which anti-retroviral HIV/AIDS drugs were being patented.Pages
